HK1121670A1 - Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use - Google Patents

Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use

Info

Publication number
HK1121670A1
HK1121670A1 HK08110565.6A HK08110565A HK1121670A1 HK 1121670 A1 HK1121670 A1 HK 1121670A1 HK 08110565 A HK08110565 A HK 08110565A HK 1121670 A1 HK1121670 A1 HK 1121670A1
Authority
HK
Hong Kong
Prior art keywords
composition
inter
preparation
therapeutic use
human plasma
Prior art date
Application number
HK08110565.6A
Inventor
Yow-Pin Lim
Djuro Josic
Douglas C Hixson
Original Assignee
Prothera Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2004/036848 external-priority patent/WO2005046587A2/en
Application filed by Prothera Biolog filed Critical Prothera Biolog
Publication of HK1121670A1 publication Critical patent/HK1121670A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to an inner-alpha inhibitor protein (I alpha Ip). The invention also relates to a method for purifying the I alpha Ip composition and the usage for treating the human diseases such as pyaemia, septicemic shock, atrophic arthritis, cancer and infectious disease.
HK08110565.6A 2004-11-05 2008-09-23 Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use HK1121670A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/036848 WO2005046587A2 (en) 2003-11-08 2004-11-05 Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use

Publications (1)

Publication Number Publication Date
HK1121670A1 true HK1121670A1 (en) 2009-04-30

Family

ID=39307922

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08110565.6A HK1121670A1 (en) 2004-11-05 2008-09-23 Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use

Country Status (2)

Country Link
CN (1) CN101160133B (en)
HK (1) HK1121670A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7932365B2 (en) 2003-11-08 2011-04-26 Pro Thera Biologics, Llc Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
AU2009260822B2 (en) 2008-05-28 2016-09-22 Prothera Biologics, Inc. Preparation and composition of Inter-alpha inhibitor proteins from blood
US20100158893A1 (en) * 2008-12-19 2010-06-24 Baxter International Inc. Systems and methods for obtaining immunoglobulin from blood
FR2946348B1 (en) * 2009-06-05 2011-08-05 Lab Francais Du Fractionnement PROCESS FOR PREPARING A HIGH-DEPTH PURITY PROTHROMBIC COMPLEX COMPOSITION
SG187599A1 (en) * 2010-07-23 2013-03-28 Baxter Int Manufacture of inter -alpha - inhibitor proteins (iaip) from plasma
CA2885604A1 (en) 2012-09-09 2014-03-13 Prothera Biologics, Inc. Treatment of ischemia using inter-alpha inhibitor proteins
CN112316148A (en) * 2019-08-01 2021-02-05 成都夸常奥普医疗科技有限公司 Use of a semi-fluid comprising plasma, pharmaceutical compositions comprising the semi-fluid and an active ingredient and process for preparing the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1326893A2 (en) * 2000-10-13 2003-07-16 Octapharma AG Plasma fraction containing bikunin, method for the production thereof and use of the same

Also Published As

Publication number Publication date
CN101160133B (en) 2013-01-09
CN101160133A (en) 2008-04-09

Similar Documents

Publication Publication Date Title
AU2002360592A8 (en) Inhibitors of hepatitis c virus
NO20055863L (en) W-carboxyaryl-substituted diphenylurea compounds as raf kinase inhibitors
AU2003299519A8 (en) Hepatitis c virus inhibitors
PL373398A1 (en) Heterocyclicsulfonamide hepatitis c virus inhibitors
HK1121670A1 (en) Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
EP1408986A4 (en) Proteomimetic compounds and methods
ATE451376T1 (en) COMPOSITIONS SUITABLE AS INHIBITORS OF PROTEIN KINASES
MY140840A (en) Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
WO2005013892A3 (en) Hydrolytically-resistant boron-containing therapeutics and methods of use
MXPA06011327A (en) Azaindoles useful as inhibitors of jak and other protein kinases.
NO20063193L (en) Fused pyrrolocarbazoles and processes for their preparation
ZA200900935B (en) Hepatitis C virus inhibitors
TW200508214A (en) Novel compounds
MY140710A (en) Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
ATE473980T1 (en) TRIAZOLOPYRIDAZINE AS PROTEIN KINASE INHIBITORS
WO2004024097A8 (en) Compositions and methods for the treatment of immune related diseases
NO20063196L (en) New fused pyrrolocarbazoles
MA27880A1 (en) TETRAHYDROCARBAZOLE DERIVATIVES AND THEIR PHARMACEUTICAL USE
MXPA05009885A (en) Novel fused triazolones and the uses thereof.
UA87494C2 (en) Azaindoles useful as inhibitors of jak and other protein kinases
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
WO2005046587A3 (en) Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
EP1802297A4 (en) Compositions and methods for treatment of disease caused by yersinia spp infection
MXPA06000460A (en) IMPROVED RECOMBINANT HUMAN INTERFERON-BETA-1b POLYPEPTIDES.
UA87829C2 (en) Fused pyrrolocarbazoles